Fortitude Family Office, LLC

Family Office

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1950506 SCOTTSDALE, AZ

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$17,459

-$1,857 QoQ

Shares Held

+12.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,191

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $736,227 across 148 Biotechnology names. REGN ranks #9 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	523	$157,438
2	INCY	Incyte Corp	641	$72,663
3	RVMD	Revolution Medicines, Inc.	292	$54,685
4	VRTX	Vertex Pharmaceuticals Inc / Ma	72	$35,764
5	JAZZ	Jazz Pharmaceuticals plc	128	$30,844
6	FTRE	Fortrea Holdings Inc.	1,647	$28,657
7	RLAY	Relay Therapeutics, Inc.	1,268	$23,724
8	ARWR	Arrowhead Pharmaceuticals, Inc.	228	$18,584

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,459	28	+12.0%	Shares	Sole	2026-07-20
2026-03-31	$19,316	25	+127.3%	Shares	Sole	2026-04-16
2025-12-31	$8,490	11	-26.7%	Shares	Sole	2026-01-15
2025-09-30	$8,434	15	-16.7%	Shares	Sole	2025-10-17
2025-06-30	$9,450	18	-66.7%	Shares	Sole	2025-07-15
2025-03-31	$34,248	54	0.0%	Shares	Sole	2025-04-16
2024-12-31	$38,465	54	-3.6%	Shares	Sole	2025-01-10
2024-09-30	$58,869	56	0.0%	Shares	Sole	2024-10-25
2024-06-30	$58,857	56	+60.0%	Shares	Sole	2024-07-10
2024-03-31	$33,687	35	0.0%	Shares	Sole	2024-04-11
2023-12-31	$30,740	35	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.